Truvada ruling could allow cheap HIV prevention in the UK

Cheap copies of Gilead’s HIV drug Truvada, which can also be used to reduce the risk of people becoming infected, could be available in the UK following a court ruling. Truvada (tenofovir disoproxil+emtricitabine) is used as the backbone of many HIV combination therapies, and the decision paves the way for much cheaper therapies for people who need to take drugs to suppress their infection and prevent it turning into AIDS. But Truvada can also be used for HIV pre-exposure prophylaxis (PrEP), as it has been shown to reduce the risk of infection in people who are newly exposed to the virus.